DEXTROMETHORPHAN METABOLISM IN RAT - INTERSTRAIN DIFFERENCES AND THE FATE OF INDIVIDUALLY ADMINISTERED OXIDATIVE METABOLITES

被引:15
作者
BOCHNER, F [1 ]
SOMOGYI, AA [1 ]
CHEN, ZR [1 ]
机构
[1] ROYAL ADELAIDE HOSP,DEPT CLIN PHARMACOL,ADELAIDE,SA 5000,AUSTRALIA
基金
英国医学研究理事会;
关键词
D O I
10.3109/00498259409043257
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Dextromethorphan undergoes O- and N-demethylation, with the resultant metabolites being further N- and O-demethylated respectively to 5-hydroxymorphinan. The polymorphically expressed O-demethylation reaction is catalysed by P4502D1 in the Sprague-Dawley (SD) rat. The Dark-Agouti (DA) rat lacks this enzyme. 2. The aims were: (1) to determine if there were strain differences also in the Hooded Wistar (HW) and Albino Wister (AW) rats with respect to the four demethylation reactions after dextromethorphan 20 mg/kg intraperitoneally; (2) to investigate the inhibition of the demethylation reactions by quinine and quinidine (each 40 mg/kg i.p.) in the above strains; and (3) to investigate the fate of separately administered metabolites (5 mg/kg i.p.) of dextromethorphan in the SD strain. 3. The total recovery of dextromethorphan and metabolites in the four strains ranged from 38 to 64% of the dose. The O-demethylation ratios (expressed as the ratio of urinary total dextrorphan divided by dextromethorphan) in the AW and DA strains were similar but less than in the SD/HW strains; the N-demethylation ratios (expressed as the ratio of urinary total 3-hydroxymorphinan plus 5-methoxymorphinan divided by dextromethorphan) in the DA and SD strains were similar but greater than in the AW and HW strains. Quinine and quinidine significantly reduced the O-demethylation ratio in the SD and DA rat strains, and the N-demethylation ratio in the SD strain. 4. In the SD rat the major metabolic route was via O-demethylation to dextrorphan. The source of 3-hydroxymorphinan is primarily from N-demethylation of dextromethorphan to 3-methoxymorphinan and its subsequent O-demethylation to 3-hydroxymorphinan. The O-demethylation metabolic ratio for dextromethorphan should be calculated as the quotient of urinary total dextrorphan divided by dextromethorphan.
引用
收藏
页码:543 / 552
页数:10
相关论文
共 20 条
  • [1] ANIMAL MODELING OF HUMAN POLYMORPHIC DRUG OXIDATION - THE METABOLISM OF DEBRISOQUINE AND PHENACETIN IN RAT INBRED STRAINS
    ALDABBAGH, SG
    IDLE, JR
    SMITH, RL
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (03) : 161 - 164
  • [3] BUFURALOL 1'-HYDROXYLASE ACTIVITY OF THE RAT - STRAIN DIFFERENCES AND THE EFFECTS OF INHIBITORS
    BOOBIS, AR
    SEDDON, CE
    DAVIES, DS
    [J]. BIOCHEMICAL PHARMACOLOGY, 1986, 35 (17) : 2961 - 2965
  • [4] NASAL DELIVERY OF [C-14] DEXTROMETHORPHAN HYDROCHLORIDE IN RATS - LEVELS IN PLASMA AND BRAIN
    CHAR, H
    KUMAR, S
    PATEL, S
    PIEMONTESE, D
    IQBAL, K
    MALICK, AW
    SALVADOR, RA
    BEHL, CR
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (08) : 750 - 752
  • [5] SIMULTANEOUS DETERMINATION OF DEXTROMETHORPHAN AND 3 METABOLITES IN PLASMA AND URINE USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH APPLICATION TO THEIR DISPOSITION IN MAN
    CHEN, ZR
    SOMOGYI, AA
    BOCHNER, F
    [J]. THERAPEUTIC DRUG MONITORING, 1990, 12 (01) : 97 - 104
  • [6] GUENGERICH FP, 1986, MOL PHARMACOL, V30, P287
  • [7] CYP2D6-DEPENDENT AND CYP3A-DEPENDENT METABOLISM OF DEXTROMETHORPHAN IN HUMANS
    JACQZAIGRAIN, E
    FUNCKBRENTANO, C
    CRESTEIL, T
    [J]. PHARMACOGENETICS, 1993, 3 (04): : 197 - 204
  • [8] KAMM JJ, 1967, J PHARMACOL EXP THER, V158, P437
  • [9] PRIMARY AND SECONDARY OXIDATIVE-METABOLISM OF DEXTROMETHORPHAN - INVITRO STUDIES WITH FEMALE SPRAGUE-DAWLEY AND DARK AGOUTI RAT-LIVER MICROSOMES
    KERRY, NL
    SOMOGYI, AA
    MIKUS, G
    BOCHNER, F
    [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 45 (04) : 833 - 839
  • [10] THE SPECIFICITY OF INHIBITION OF DEBRISOQUINE 4-HYDROXYLASE ACTIVITY BY QUINIDINE AND QUININE IN THE RAT IS THE INVERSE OF THAT IN MAN
    KOBAYASHI, S
    MURRAY, S
    WATSON, D
    SESARDIC, D
    DAVIES, DS
    BOOBIS, AR
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (17) : 2795 - 2799